BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
42.78
-0.40 (-0.93%)
At close: Jul 1, 2025, 4:00 PM
42.00
-0.78 (-1.82%)
After-hours: Jul 1, 2025, 7:07 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $8.12 billion as of July 1, 2025. Its market cap has increased by 51.36% in one year.
Market Cap
8.12B
Enterprise Value
9.44B
1-Year Change
51.36%
Ranking
Category
Stock Price
$42.78
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $8.12B, an increase of 144.69%. That is a compound annual growth rate of 16.04%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.90B |
| Johnson & Johnson | 366.35B |
| AbbVie | 323.18B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 279.57B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 234.93B |
| AstraZeneca | 217.42B |